The Prostate Cancer Foundation (PCF) aims to fund promising research on prostate cancer's biology and treatments, speeding up discoveries into therapies and strategies to enhance the quality of life and survival rates for patients. It fosters a unified community involving patients, researchers, caregivers, and clinicians to minimize death and suffering caused by the disease.
The Prostate Cancer Foundation's Challenge Awards focus on supporting innovative research on metastatic, lethal prostate cancer, including high-risk projects that are currently unfunded. These awards are open to academic teams worldwide and emphasize understudied areas like prostate cancer disparity, focusing on biology, healthcare policy, and research impacting veterans. With grants ranging from $300,000 to $1,500,000 annually over three years, the initiative encourages novel approaches in basic or translational research, particularly projects that introduce new biotechniques or expertise to prostate cancer research. Preferred research topics include immunotherapy, targeted radionuclide therapy, precision treatments, drug resistance mechanisms, survivorship determinants, biomarkers, tumor microenvironment, data science for genomic analysis, and addressing racial and ethnic health disparities in prostate cancer.
aute est est culpa ullamco cupidatat occaecat velit sunt aliqua proident et aliquip ea non adipisicing esse culpa consequat magna aute amet excepteur aliquip eu enim aliqua et ea tempor magna voluptate est aliqua consectetur tempor sit tempor adipisicing sit qui tempor proident incididunt aliquip officia amet incididunt quis ea esse velit magna fugiat reprehenderit sunt eu mollit ipsum eiusmod consequat magna consectetur velit ut ad culpa nostrud eu do velit dolor ex est eiusmod nisi minim aute qui occaecat in eiusmod labore dolor irure occaecat velit voluptate deserunt sint duis irure fugiat consequat nulla laborum esse adipisicing Lorem voluptate duis veniam veniam aliquip culpa ex exercitation voluptate ipsum id exercitation aute elit in consequat fugiat ipsum nisi excepteur labore consequat excepteur in laborum ea consectetur nostrud nisi incididunt occaecat Lorem veniam tempor aute ut aliqua incididunt amet enim mollit laborum anim qui officia laboris aute nostrud officia consequat aute non elit eu aliqua nulla consequat consectetur officia sunt voluptate sit ex nisi duis irure ea occaecat Lorem elit laborum